Latest News from International Orgnization

Sudan civilians trapped by fear, disappearance and detention: rights experts

As Sudan’s conflict enters a fourth year, civilians are increasingly trapped not only by frontline violence but by fear, disappearance and detention, according to an update by the Independent International Fact-Finding Mission for the Sudan to the 62nd Session of the UN Human Rights Council in Geneva on Monday. 

Sudan civilians trapped by fear, disappearance and detention: rights experts Read More »

Deadline for submitting proposals for the 2026 Public Forum extended to 17 June

The deadline for submitting proposals for this year’s Public Forum — entitled Powering the Future — has been extended to 17 June 2026. Individuals interested in organizing sessions at the Forum, to be held from 15 to 17 September, are invited to complete an online application form.

Deadline for submitting proposals for the 2026 Public Forum extended to 17 June Read More »

CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026

SHANGHAI, June 14, 2026 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces poster presentations for CT0596 (an allogeneic CAR T-cell product targeting BCMA), and CT1190B (an allogeneic CAR…

CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026 Read More »

Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape

The case, originally filed in 2021 by Harbour Antibodies, asserted that Amgen and Teneobio (an Amgen subsidiary) infringed patents protecting Harbour’s groundbreaking antibody discovery platform Delaware jury finds infringement willful and patent valid, and awards full $20.2 million in…

Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape Read More »

Die Menarini Group präsentiert auf dem Kongress der European Hematology Association (EHA) 2026 Daten aus der Phase-3-Studie SENTRY zur Kombination von Selinexor und Ruxolitinib bei Myelofibrose

Die Kombination aus Selinexor und Ruxolitinib erreichte den ersten koprimären Endpunkt und zeigte in Woche 24 eine statistisch signifikante Verbesserung der Milzvolumenreduktion (SVR35) von 49,8 % in der Kombinationsgruppe gegenüber 28 % in der Kontrollgruppe. Eine Post-hoc-Analyse der…

Die Menarini Group präsentiert auf dem Kongress der European Hematology Association (EHA) 2026 Daten aus der Phase-3-Studie SENTRY zur Kombination von Selinexor und Ruxolitinib bei Myelofibrose Read More »

Muscle Growth Supplements Featuring Magnesium, Ashwagandha and Omega-3s Are Highlighted by PureHealth Research

MANASSAS, Va., June 14, 2026 /PRNewswire/ — Strength, mobility, and recovery are getting more attention from people who want to stay active for the long haul, and PureHealth Research is highlighting that growing interest in proactive muscle wellness. The company’s collection brings…

Muscle Growth Supplements Featuring Magnesium, Ashwagandha and Omega-3s Are Highlighted by PureHealth Research Read More »

Scroll to Top
Verified by MonsterInsights